Headquartered in Rancho Cordova, California, SK pharmteco is a global contract development and manufacturing organization specializing in the production of active pharmaceutical ingredients (APIs), advanced intermediates, and cell and gene therapy for the pharmaceutical industry. Built on 80 years of experience, our global operations have the capability and capacity to support client needs from development through commercial production. SK pharmteco is owned by SK Inc., the strategic investment arm of South Korea’s SK Group.
| Website | https://www.skpharmteco.com |
| Revenue | $675.1 million |
| Employees | 1,431 (390 on RocketReach) |
| Founded | 2019 |
| Address | Akron St 100, Rancho Cordova, California 95742, US |
| Technologies |
JavaScript
,
HTML
,
PHP
+19 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing |
| Keywords | Api Manufacturing, Pharmaceutical Manufacturing, Contract Development Manufacturing Organization, Active Pharmaceutical Ingredients, Pharmaceutical Development, Pharmaceutical Production, Cdmo, Cell And Gene Therapy, Drug Substance Manufacturing, Drug Production, Contract Manufacturing, Advanced Intermediates, Process Development, Biologics Manufacturing, Custom Synthesis, Medicinal Chemistry, Analytical Testing, Quality Control, Regulatory Affairs |
| Competitors | Thermo Fisher Scientific, BASF, Boehringer Ingelheim, FUJIFILM Diosynth Biotechnologies, Catalent Pharma Solutions, Evonik, WuXi AppTec, Lonza, AMRI (Albany Molecular Research Inc.), Samsung Biologics +45 more (view full list) |
Looking for a particular SK pharmteco employee's phone or email?
The SK pharmteco annual revenue was $675.1 million in 2026.
Joerg Ahlgrimm is the CEO of SK pharmteco.
390 people are employed at SK pharmteco.
SK pharmteco is based in Rancho Cordova, California.